--- title: "Jamieson Wellness (TSE:JWEL) Stock Price Down 0.4% - Here's Why" type: "News" locale: "en" url: "https://longbridge.com/en/news/282754042.md" description: "Jamieson Wellness (TSE:JWEL) stock fell 0.4% to C$34.27, with trading volume down 56% from average levels. Analysts have raised price targets, with National Bank Financial setting it at C$45.00 and TD Securities at C$48.00, both maintaining 'buy' ratings. The company reported C$0.90 EPS and C$277.66 million in revenue last quarter. A quarterly dividend of $0.23 per share was recently paid, yielding 2.7%. Despite a current 'buy' rating, some analysts suggest better investment opportunities exist." datetime: "2026-04-14T23:19:28.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282754042.md) - [en](https://longbridge.com/en/news/282754042.md) - [zh-HK](https://longbridge.com/zh-HK/news/282754042.md) --- # Jamieson Wellness (TSE:JWEL) Stock Price Down 0.4% - Here's Why Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) traded down 0.4% during trading on Tuesday . The stock traded as low as C$34.26 and last traded at C$34.27. 36,634 shares changed hands during mid-day trading, a decline of 56% from the average session volume of 84,085 shares. The stock had previously closed at C$34.40. Get **Jamieson Wellness** alerts: ## Wall Street Analyst Weigh In JWEL has been the topic of a number of research analyst reports. National Bank Financial raised their price objective on shares of Jamieson Wellness from C$40.50 to C$45.00 and gave the stock an "outperform" rating in a report on Monday, February 23rd. TD Securities lifted their price objective on shares of Jamieson Wellness from C$46.00 to C$48.00 and gave the company a "buy" rating in a research report on Monday, March 2nd. Finally, Canadian Imperial Bank of Commerce set a C$43.00 price objective on shares of Jamieson Wellness and gave the company an "outperform" rating in a research report on Tuesday, March 24th. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of C$44.00. **Get Our Latest Report on JWEL** ## Jamieson Wellness Stock Performance The stock's 50 day moving average price is C$35.71 and its 200 day moving average price is C$34.88. The company has a market cap of C$1.41 billion, a price-to-earnings ratio of 23.47 and a beta of 1.46. The company has a current ratio of 2.59, a quick ratio of 1.08 and a debt-to-equity ratio of 97.24. Jamieson Wellness (TSE:JWEL - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported C$0.90 earnings per share (EPS) for the quarter. The firm had revenue of C$277.66 million during the quarter. Jamieson Wellness had a return on equity of 12.97% and a net margin of 7.60%. On average, analysts expect that Jamieson Wellness Inc. will post 2.1438892 EPS for the current fiscal year. ## Jamieson Wellness Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 16th were paid a dividend of $0.23 per share. The ex-dividend date of this dividend was Friday, March 6th. This represents a $0.92 annualized dividend and a yield of 2.7%. Jamieson Wellness's dividend payout ratio (DPR) is currently 60.27%. ## Jamieson Wellness Company Profile (Get Free Report) Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market. ## Read More - Five stocks we like better than Jamieson Wellness _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Jamieson Wellness Right Now? Before you consider Jamieson Wellness, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list. While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [JWEL.US](https://longbridge.com/en/quote/JWEL.US.md) - [CM.US](https://longbridge.com/en/quote/CM.US.md) ## Related News & Research - [RBC Capital Sticks to Its Buy Rating for Jamieson Wellness Inc (JWEL)](https://longbridge.com/en/news/285790968.md) - [Jamieson Wellness Sets Date for Q4 and Full-Year 2025 Results and Investor Call](https://longbridge.com/en/news/275819580.md) - [WELL Health Technologies (TSX:WELL) Valuation Check After New Chief Health Officer Appointment](https://longbridge.com/en/news/288915262.md) - [Amazon issues record-setting Canadian dollar-denominated corporate bond deal](https://longbridge.com/en/news/289215710.md) - [Fox Run Management L.L.C. Purchases Shares of 7,520 Welltower Inc. $WELL](https://longbridge.com/en/news/289173677.md)